| Literature DB >> 26523602 |
Luisa F Pallares1, Peter Carbonetto2, Shyam Gopalakrishnan2, Clarissa C Parker2, Cheryl L Ackert-Bicknell3, Abraham A Palmer4, Diethard Tautz1.
Abstract
The vertebrate cranium is a prime example of the high evolvability of complex traits. While evidence of genes and developmental pathways underlying craniofacial shape determination is accumulating, we are still far from understanding how such variation at the genetic level is translated into craniofacial shape variation. Here we used 3D geometric morphometrics to map genes involved in shape determination in a population of outbred mice (Carworth Farms White, or CFW). We defined shape traits via principal component analysis of 3D skull and mandible measurements. We mapped genetic loci associated with shape traits at ~80,000 candidate single nucleotide polymorphisms in ~700 male mice. We found that craniofacial shape and size are highly heritable, polygenic traits. Despite the polygenic nature of the traits, we identified 17 loci that explain variation in skull shape, and 8 loci associated with variation in mandible shape. Together, the associated variants account for 11.4% of skull and 4.4% of mandible shape variation, however, the total additive genetic variance associated with phenotypic variation was estimated in ~45%. Candidate genes within the associated loci have known roles in craniofacial development; this includes 6 transcription factors and several regulators of bone developmental pathways. One gene, Mn1, has an unusually large effect on shape variation in our study. A knockout of this gene was previously shown to affect negatively the development of membranous bones of the cranial skeleton, and evolutionary analysis shows that the gene has arisen at the base of the bony vertebrates (Eutelostomi), where the ossified head first appeared. Therefore, Mn1 emerges as a key gene for both skull formation and within-population shape variation. Our study shows that it is possible to identify important developmental genes through genome-wide mapping of high-dimensional shape features in an outbred population.Entities:
Mesh:
Year: 2015 PMID: 26523602 PMCID: PMC4629907 DOI: 10.1371/journal.pgen.1005607
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917
Fig 1SNP heritability of individual PCs.
Correlation between SNP heritability and proportion of variation explained by the PC is shown for (a) mandible and (b) skull. Grey dots represent PCs. In (c) and (d), numbers above the bars indicate the proportion of each bar that is colored dark grey, this is the SNP heritability of each PC. The error bars give standard error of the SNP heritability estimates.
Fig 2Chromosomal partition of the variance.
These plots compare the contribution of each chromosome to (a) mandible and (b) skull shape variation, and how these contributions correlate with chromosome length (in Mb).
Fig 3Genome-wide scans for (a) mandible and (b) skull.
This plot shows p-values for association with craniofacial phenotypes—22 skull shape PCs, 21 mandible shape PCs and centroid size—at 80,027 candidate SNPs. Since only the smallest p-values are visible from this plot, p-values for individual PCs are drawn in separate plots; see S9 and S10 Figs. The associated phenotype (PC or centroid size) is indicated for each QTL. The blue line represents an approximate genome-wide significance threshold, 1e-6 (-log(p) = 6); the actual threshold we used to determine significance of the p-values is different for each phenotype (average–log(p) = 6.05, min = 5.95, max = 6.16). *To improve visualization, the p-value shown in the Figure is larger than the actual p-value; the actual p-values are PC4* -log(p) = 26.6, PC3* -log(p) = 14.8.
SNPs associated with skull phenotypes (PCs).
Columns of the table show the SNP with the lowest p-value per QTL, its base-pair position, p-value calculated in GEMMA, and the proportion of total skull shape variation explained by the SNP (%varSkull).
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| 1 | PC1 | 11 | 32367260 | rs258942042 | 9.13E-07 | 0.75 |
|
| 2 | PC1 | 13 | 110231696 | rs245694506 | 3.93E-07 | 0.86 |
|
| 3 | PC2 | 8 | 80889309 | rs228570244 | 7.54E-07 | 0.62 |
|
| 4 | PC3 | 5 | 111328046 | rs33702397 | 2.18E-27 | 2.05 |
|
| 5 | PC4 | 9 | 99713529 | rs30491142 | 9.69E-09 | 0.44 |
|
| 6 | PC5 | 2 | 33284278 | rs27194486 | 5.74E-07 | 0.35 |
|
| 7 | PC5 | 9 | 98588137 | rs13466556 | 4.35E-09 | 0.56 |
|
| 8 | PC6 | 5 | 111626960 | rs254983846 | 1.53E-08 | 1.27 |
|
| 9 | PC6 | 19 | 4165856 | rs37378594 | 3.24E-08 | 0.48 |
|
| 10 | PC7 | 13 | 31734894 | cfw-13-31734894 | 4.00E-09 | 0.53 |
|
| 11 | PC8 | 3 | 98931976 | rs30352013 | 4.71E-07 | 0.38 |
|
| 12 | PC8 | 5 | 110918274 | rs227631022 | 2.63E-09 | 1.15 |
|
| 13 | PC12 | 11 | 32423285 | rs26862534 | 9.48E-07 | 0.40 |
|
| 14 | PC19 | 11 | 95634099 | rs26992385 | 8.83E-07 | 0.20 |
|
| 15 | PC20 | 2 | 83096089 | rs46747509 | 9.08E-07 | 0.61 |
|
| 16 | PC20 | 11 | 94881746 | rs50079241 | 1.29E-07 | 0.47 |
|
| 17 | PC22 | 15 | 11384042 | rs31584944 | 9.85E-07 | 0.25 |
|
Principal component (PC). %varSkull is the proportion of variation in skull shape explained by the SNP. This value was calculated in a multivariate regression of shape on the SNP genotype. The candidate genes were identified based on their role in bone morphogenesis (see methods). Empty cells (-) mean no compelling candidate gene emerged. The total set of genes in the QTL regions is shown in S4Table
† Regions that overlap with Maga et al 2015
* Regions that overlap with Attanasio et al 2014 using a window of 500Kb around the focal SNP
** Regions that overlap with Attanasio et al 2014 using a window of 1Mb around the focal SNP
SNPs associated with mandible phenotypes (PCs).
Columns of the table show the SNP with the lowest p-value per QTL, its base-pair position, p-value calculated in GEMMA, and the proportion of total skull shape variation explained by the SNP (%varMand).
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
| 1 | PC4 | 5 | 111018365 | rs33217671 | 1.66E-15 | 1.28 |
|
| 2 | PC7 | 5 | 111426493 | rs33614268 | 7.63E-10 | 1.44 |
|
| 3 | PC7 | 11 | 35295119 | rs28219152 | 2.66E-08 | 0.44 |
|
| 4 | PC8 | 9 | 99595168 | rs29977169 | 6.18E-07 | 0.27 |
|
| 5 | PC12 | 6 | 107312800 | rs36343125 | 7.93E-07 | 0.22 |
|
| 6 | PC15 | 14 | 98935309 | rs237064333 | 1.68E-08 | 0.22 |
|
| 7 | PC19 | 11 | 96261688 | rs233696367 | 8.25E-07 | 0.31 |
|
| 8 | PC20 | 4 | 90510654 | rs221759350 | 6.48E-07 | 0.26 |
|
| 9 | Centroid size | 1 | 153481175 | rs32618422 | 5.96E-09 | 5.08 |
|
Principal component (PC). Centroid size (CS). %varMand is the proportion of variation in mandible shape explained by the SNP. This value was calculated in a multivariate regression of shape on the SNP genotype. The candidate genes were identified based on their role in bone morphogenesis (see methods). Empty cells (-) mean no clear candidate gene emerged. The total set of genes in the QTL regions is shown in S5 Table
† Regions that overlap with Maga et al 2015
‡ Region that overlap with Pallares et al 2014
* Regions that overlap with Attanasio et al 2014 using a window of 500Kb around the focal SNP
** Regions that overlap with Attanasio et al 2014 using a window of 1Mb around the focal SNP
Fig 4Changes in mandible (a-c) and skull (d-g) shape associated with the SNPs of largest effect.
SNP rs33702397 explains 2% of skull shape variation, and rs33614268 explains 1.4% of mandible shape variation. The sample mean shape is depicted in grey (dotted line). In orange (continuous line) is the mean shape associated to the SNP effect, scaled 10x. For mandible, (a) lateral, (b) frontal, and (c) dorsal views are shown. For skull, (d) dorsal, (e) frontal, (f) lateral, and (g) ventral views are shown. Dots and numbers represent relevant landmarks for each view.
Fig 5Effect size of peak SNPs (lowest p-value in each QTL) associated with (a) mandible and (b) skull shape.
Together the peak SNPs explain 11.4% of variation in skull shape, and 4.4% of variation in mandible shape.
Previously published findings supporting involvement of candidate genes in craniofacial phenotypes, in alphabetic order by gene.
| Gene | Biochemical function | Developmental function | Mutant phenotype | Human disease association |
|---|---|---|---|---|
|
| structural component of tight junctions | expressed in osteoblasts [ | decreased total body bone mineral density, trabecular bone volume, and cortical thickness [ | |
|
| extracellular matrix protein | main component of connective tissues | shows decreased bone volume/tissue volume and reduced trabecular number; exhibits mechanically weak, brittle, fracture-prone bones [ | osteogenesis imperfecta, a human syndrome characterized by bone fragility; subjects also show craniofacial alterations and deficient osteogenesis [ |
|
| transcription factor with homeobox domain | regulates adult bone mass and remodeling [ | branchial arch specification and craniofacial defects [ | tricho-dento-osseos syndrome (TDO) in humans, characterized by increased bone mineral density, craniofacial defects, and abnormal teeth and hair [ |
|
| transcription factor with forkhead domain | interacts with BMP signaling and | congenital hydrocephalus with calvaria bones absent [ | Axenfeld-Rieger syndrome, includes among other defects abnormalities in teeth and jaw [ |
|
| transcription factor with forkhead domain | among other functions, is also active in cranial neural crest cells and cranial mesodermal cells [ | muscular and skeletal craniofacial malformations [ | blepharophimosis, ptosis, epicanthus inversus syndrome (BPES) characterized by eyelid and craniofacial malformations and ovarian failure [ |
|
| adaptor molecule with pleckstrin domain | involved in intracellular signaling cascades of EGFR and FGFR and cytokine receptors [ | embryonic lethal [ | |
|
| phosphatase involved in phosphatidylinositol signaling pathways | represses osteoclast differentiation by regulation of the transcription factor | bone loss and osteoporosis [ | BMD variation in pre-menopausal women [ |
|
| integrin family of transmembrane proteins | heterodimer Itgav-Itgb3 is characteristic of osteoclasts, regulating its apoptosis and the process of bone resorption [ | various phenotypes, including cleft palate [ | |
|
| transcription factor with Krüppel-like zinc finger domain | regulates the commitment of ES cells to mesoderm lineage [ | affects tooth development [ | |
|
| transcription factor with homeobox domain | involved in a variety of developmental processes, including limbs, brain, kidney, eye, and calvarial bones [ | multiple calvarial defects [ | Nail-patella syndrome (NPS) including limb defects [ |
|
| transcriptional activator | modifies vitamin D [ | craniofacial defects affecting exclusively membranous bones in the skull [ | involved in craniofacial deformations [ |
|
| natriuretic peptide receptor | among other functions, it isinvolved in differentiation and proliferation of bone cells [ | skeletal-overgrowth syndrome with endochondral ossification defects [ | |
|
| regulatory GTPase | regulates vesicular trafficking in the cell, is expressed in mouse calvaria osteoblast and is thought to play a role in bone mineralization [ | in cell culture studies it regulates the formation of the ruffled membrane, the resorptive organelle of the osteoclast [ | |
|
| phosphodiesterase specific for cAMP degradation | expressed in calvaria osteoblasts [ | regulates osteoblast differentiation in vitro by degrading cAMP [ | Acrodysostosis, skeletal syndrome including nasal hypoplasia and skull deformities [ |
|
| substrate of Src tyrosine kinase | involved in EGF signaling pathway [ | craniofacial and skeleton malformations in mice [ | syndromes with craniofacial deformities, Frank-Ter Haar syndrome [ |
|
| transcription factor with T-box domain | involved in early endochondral bone development in prehypertrophic chondrocytes of cartilaginous templates [ | general reduction of bone size and changes of bone shape [ | Cousin syndrome including craniofacial dysmorphism [ |